Literature DB >> 27065580

Nodal Follicular Lymphomas: A Clinicopathological Study from a Tertiary Care Centre in South India.

Divya Supari1, Anuradha Ananthamurthy1.   

Abstract

The aim of this study was to assess the distribution of nodal follicular lymphomas (FL) among various subtypes of non- Hodgkin lymphoma and to study their clinico-pathological features. Clinical details, histomorphology including grading & patterns and immunoprofile of 44 cases were studied. Majority of the cases were grade 1 (61 %) FL. BCL2 positivity was higher in low grade FLs (97 %). An associated diffuse large B cell lymphoma component was seen in 18 % and was present only in conjunction with grade 3 FL. Majority of our patients (76 %) had a high FLIPI score and belonged to the high risk group. Our study showed that the incidence of FLs is much lower in the Indian population (14.5 %) when compared to western studies and majority were of low grade. Although there was complete initial response to treatment, relapse was common and was much higher in low grade FLs with diffuse areas on histology, Ann Arbor stage III/IV and FLIPI scores of 3-5.

Entities:  

Keywords:  FL; FLIPI; Follicular lymphoma; Low grade B cell lymphoma

Year:  2015        PMID: 27065580      PMCID: PMC4789008          DOI: 10.1007/s12288-015-0610-6

Source DB:  PubMed          Journal:  Indian J Hematol Blood Transfus        ISSN: 0971-4502            Impact factor:   0.900


  14 in total

1.  Insights into the molecular pathogenesis of follicular lymphoma arising from analysis of geographic variation.

Authors:  James J Biagi; John F Seymour
Journal:  Blood       Date:  2002-06-15       Impact factor: 22.113

2.  Distribution of various subtypes of non-Hodgkin's lymphoma in India: a study of 2773 lymphomas using R.E.A.L. and WHO Classifications.

Authors:  K N Naresh; V Srinivas; C S Soman
Journal:  Ann Oncol       Date:  2000       Impact factor: 32.976

3.  Frontline therapy with rituximab added to the combination of cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) significantly improves the outcome for patients with advanced-stage follicular lymphoma compared with therapy with CHOP alone: results of a prospective randomized study of the German Low-Grade Lymphoma Study Group.

Authors:  Wolfgang Hiddemann; Michael Kneba; Martin Dreyling; Norbert Schmitz; Eva Lengfelder; Rudolf Schmits; Marcel Reiser; Bernd Metzner; Harriet Harder; Susanna Hegewisch-Becker; Thomas Fischer; Martin Kropff; Hans-Edgar Reis; Mathias Freund; Bernhard Wörmann; Roland Fuchs; Manfred Planker; Jörg Schimke; Hartmut Eimermacher; Lorenz Trümper; Ali Aldaoud; Reza Parwaresch; Michael Unterhalt
Journal:  Blood       Date:  2005-08-25       Impact factor: 22.113

4.  CD10-MUM1+ follicular lymphoma lacks BCL2 gene translocation and shows characteristic biologic and clinical features.

Authors:  Kennosuke Karube; Ying Guo; Junji Suzumiya; Yasuo Sugita; Yuko Nomura; Kohei Yamamoto; Kei Shimizu; Shirou Yoshida; Hideki Komatani; Morishige Takeshita; Masahiro Kikuchi; Naoya Nakamura; Osamu Takasu; Fumiko Arakawa; Hiroyuki Tagawa; Masao Seto; Koichi Ohshima
Journal:  Blood       Date:  2007-04-01       Impact factor: 22.113

5.  Cytomorphologic, immunohistochemical, and cytogenetic profiles of follicular lymphoma: 2 types of follicular lymphoma grade 3.

Authors:  German Ott; Tiemo Katzenberger; Andreas Lohr; Steffi Kindelberger; Thomas Rüdiger; Martin Wilhelm; Jörg Kalla; Andreas Rosenwald; Justus G Müller; M Michaela Ott; Hans Konrad Müller-Hermelink
Journal:  Blood       Date:  2002-05-15       Impact factor: 22.113

Review 6.  Decreased CD10 expression in grade III and in interfollicular infiltrates of follicular lymphomas.

Authors:  C Eshoa; S Perkins; B Kampalath; V Shidham; M Juckett; C C Chang
Journal:  Am J Clin Pathol       Date:  2001-06       Impact factor: 2.493

7.  Risk and clinical implications of transformation of follicular lymphoma to diffuse large B-cell lymphoma.

Authors:  Silvia Montoto; Andrew John Davies; Janet Matthews; Maria Calaminici; Andrew J Norton; John Amess; Sarah Vinnicombe; Rachel Waters; Ama Z S Rohatiner; T Andrew Lister
Journal:  J Clin Oncol       Date:  2007-05-07       Impact factor: 44.544

8.  Follicular lymphoma international prognostic index 2: a new prognostic index for follicular lymphoma developed by the international follicular lymphoma prognostic factor project.

Authors:  Massimo Federico; Monica Bellei; Luigi Marcheselli; Stefano Luminari; Armando Lopez-Guillermo; Umberto Vitolo; Barbara Pro; Stefano Pileri; Alessandro Pulsoni; Pierre Soubeyran; Sergio Cortelazzo; Giovanni Martinelli; Maurizio Martelli; Luigi Rigacci; Luca Arcaini; Francesco Di Raimondo; Francesco Merli; Elena Sabattini; Peter McLaughlin; Philippe Solal-Céligny
Journal:  J Clin Oncol       Date:  2009-08-03       Impact factor: 44.544

9.  Population-based analysis of incidence and outcome of transformed non-Hodgkin's lymphoma.

Authors:  Abdulwahab J Al-Tourah; Karamjit K Gill; Mukesh Chhanabhai; Paul J Hoskins; Richard J Klasa; Kerry J Savage; Laurie H Sehn; Tamara N Shenkier; Randy D Gascoyne; Joseph M Connors
Journal:  J Clin Oncol       Date:  2008-10-06       Impact factor: 44.544

10.  National Cancer Institute sponsored study of classifications of non-Hodgkin's lymphomas: summary and description of a working formulation for clinical usage. The Non-Hodgkin's Lymphoma Pathologic Classification Project.

Authors: 
Journal:  Cancer       Date:  1982-05-15       Impact factor: 6.860

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.